LOS ANGELES, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)SOLVE ME CFS INITIATIVE INC, founded in 1987, is a community nonprofit that reported $2.1M in total revenue in fiscal year 2024. Expenses of $1.9M left a modest 9% surplus.
THE SOLVE ME/CFS INITIATIVE (SOLVE M.E.) IS A NON-PROFIT ORGANIZATION THAT SERVES AS A CATALYST FOR CRITICAL RESEARCH INTO DIAGNOSTICS, TREATMENTS, AND CURES FOR MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME (ME/CFS), LONG COVID AND OTHER (CONTINUED ON SCH. O) POST-INFECTION DISEASES. OUR WORK WITH THE SCIENTIFIC, MEDICAL, AND PHARMACEUTICAL COMMUNITIES, ADVOCACY WITH GOVERNMENT AGENCIES, AND ALLIANCES WITH PATIENT GROUPS AROUND THE WORLD ARE LAYING THE FOUNDATION FOR BREAKTHROUGHS THAT CAN IMPROVE THE LIVES OF MILLIONS WHO SUFFER FROM VARIOUS ''LONG HAUL'' DISEASES.
ADVOCACY AND COMMUNICATION ACCOMPLISHMENTS: IN 2025, SOLVE M.E. ADVANCED NATIONAL AWARENESS AND POLICY MOMENTUM FOR ME/CFS AND LONG COVID THROUGH COORDINATED FEDERAL ADVOCACY AND COMMUNITY...
ADVOCACY AND COMMUNICATION ACCOMPLISHMENTS: IN 2025, SOLVE M.E. ADVANCED NATIONAL AWARENESS AND POLICY MOMENTUM FOR ME/CFS AND LONG COVID THROUGH COORDINATED FEDERAL ADVOCACY AND COMMUNITY ENGAGEMENT. DURING ADVOCACY WEEK 2025, MORE THAN 3,500 ADVOCATE EMAILS, CALLS, AND TEXTS WERE SENT TO MEMBERS OF CONGRESS TO SUSTAIN THE CDC CHRONIC FATIGUE SYNDROME PROGRAM AND ENSURE ME/CFS REMAINED ELIGIBLE UNDER THE DEPARTMENT OF DEFENSE CDMRP PROGRAM. EMILY TAYLOR, MONIQUE WIKE, AND VOLUNTEERS MET WITH OVER TWENTY CONGRESSIONAL OFFICES IN WASHINGTON, D.C., SECURING BIPARTISAN SUPPORT, WITH 11 SENATORS JOINING THE CDC DEAR COLLEAGUE LETTER AND 10 SENATORS SUPPORTING THE CDMRP REQUEST. SOLVE MAINTAINED A STRONG NON-PARTISAN STRATEGY TO KEEP RESEARCH AND PROGRAM FUNDING VIABLE ACROSS ADMINISTRATIONS. (CONTINUED ON SCH. O) EMILY TAYLOR CO-AUTHORED A WHITE PAPER PROPOSING NIH RESTRUCTURING TO BETTER SUPPORT INFECTION-ASSOCIATED CHRONIC CONDITIONS AND COLLABORATED ON THREE MAJOR RECOVER PUBLICATIONS ADVANCING SCIENTIFIC AND POLICY UNDERSTANDING. THROUGH ITS PARTNERSHIP WITH MEACTION ON THE GO LOCAL CAMPAIGN, THE LIVED EXPERIENCE TASK FORCE MICROGRANT PROGRAM, AND EDUCATIONAL WEBINARS WITH THE BATEMAN HORNE CENTER, SOLVE CONTINUED TO EXPAND GRASSROOTS LEADERSHIP, EDUCATION, AND FEDERAL ENGAGEMENT, FURTHER ELEVATING THE PATIENT VOICE IN NATIONAL DECISION-MAKING. THE SUCCESSFUL INCLUSION OF ME/CFS WITHIN THE CDMRP RESULTED IN MORE THAN $300 MILLION IN POTENTIAL RESEARCH FUNDING OPPORTUNITIES, MARKING A MAJOR MILESTONE FOR THE COMMUNITY AND THE FIELD.
RESARCH ACCOMPLISHMENTS: SOLVE'S RESEARCH INITIATIVES ACHIEVED MAJOR MILESTONES THIS YEAR THROUGH NEW AWARDS, PARTNERSHIPS, AND PLATFORM DEVELOPMENT. THE ORGANIZATION LAUNCHED A $30,000 CATALYST FUND...
RESARCH ACCOMPLISHMENTS: SOLVE'S RESEARCH INITIATIVES ACHIEVED MAJOR MILESTONES THIS YEAR THROUGH NEW AWARDS, PARTNERSHIPS, AND PLATFORM DEVELOPMENT. THE ORGANIZATION LAUNCHED A $30,000 CATALYST FUND AT YALE TO SUPPORT DR. AKIKO IWASAKI'S PIONEERING ME/CFS AND LONG COVID RESEARCH, AND PROVIDED A $37,000 CATALYST AWARD TO SIMMARON RESEARCH FOR ITS RAPAMYCIN TRIAL. ADDITIONAL RAMSAY AWARDS SUPPORTED PROJECTS BY DR. DANA YELIN AND THE UNIVERSITY COLLEGE LONDON TEAM LED BY PROFESSOR CAMBRIDGE, ENSURING CONTINUED ENGAGEMENT THROUGH PUBLIC WEBINARS AND OUTREACH. SOLVE FORMALIZED THE BIC/CODA ALLIANCE, ALIGNING WITH METRODORA AND CARE EVOLUTION TO BUILD AN INTEGRATED RESEARCH AND DATA-SHARING ECOSYSTEM. FOLLOWING A SUCCESSFUL PRESS LAUNCH REACHING AN ESTIMATED 140 MILLION PEOPLE, SOLVE COORDINATED (CONTINUED ON SCH. O) THE IRB TRANSITION TO METRODORA AND PREPARED FOR PEDIATRIC AND SPANISH-LANGUAGE EXPANSION OF THE PLATFORM. THE ORGANIZATION ALSO ENTERED A PARTNERSHIP WITH GENETIC ALLIANCE AND GALATEA FOR FREE BIOBANK STORAGE AND ENHANCED MEMBER DATA CONTROL THROUGH DIGITAL CABINET ACCESS. TOGETHER, THESE ACCOMPLISHMENTS REFLECT SOLVE'S DEEP COMMITMENT TO ACCELERATING RESEARCH, FOSTERING COLLABORATION, AND TRANSLATING SCIENCE INTO TANGIBLE PROGRESS FOR PATIENTS WORLDWIDE.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $2,091,506 | $1,947,106 | +0.1% |
| Expenses | $1,893,051 | $2,847,006 | -0.3% |
| Net Income | $198,455 | $-899,900 | -1.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| EMILY TAYLOR | PRESIDENT/CEO | 36.00 |
Officer
Director
|
$170,466 | $8,377 | $178,843 |
| JOHN NICOLS | CHAIR | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| RICK SPROUT | SECRETARY | 4.00 |
Officer
Director
|
$0 | $0 | $0 |
| MIKE ATHERTON | TREASURER | 4.00 |
Officer
Director
|
$0 | $0 | $0 |
| BARBARA LUBASH | VICE-CHAIR | 4.00 |
Officer
Director
|
$0 | $0 | $0 |
| VICTORIA BOIES | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| STEWART GITTELMAN | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| WILLIAM HASSLER | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| CAROL HEAD | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| GURDYAL KALSI | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| RONA KRAMER | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| AMRIT SHAHZAD | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| JANICE STANTON | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| CYNTHIA ADINIG | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| JOSEPH BARRERA | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| KENYA BECKMANN | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| KISTIN JACOBSON | SEE SCH. O | 36.00 |
Officer
Director
|
$86,092 | $1,965 | $88,057 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $2,091,506 | $1,893,051 | $1,110,180 | $198,455 |
| 2024 | $1,947,106 | $2,847,006 | $1,074,263 | $-899,900 |
| 2023 | $2,037,881 | $3,812,598 | $2,188,069 | $-1,774,717 |
| 2022 | $5,520,483 | $3,466,562 | $3,950,139 | $2,053,921 |
| 2021 | $2,192,325 | $2,767,949 | $1,880,953 | $-575,624 |
| 2020 | $3,669,548 | $2,788,306 | $2,460,484 | $881,242 |
| 2019 | $2,596,294 | $1,921,489 | $1,434,405 | $674,805 |
Compare SOLVE ME CFS INITIATIVE INC with other nonprofits in California and across the country.